This image is not available for purchase in your country.

Vioxx (rofecoxib) molecule

Vioxx (rofecoxib) molecule

A624/0210

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR MARK J. WINTER / SCIENCE PHOTO LIBRARY DR MARK J. WINTER / SCIENCE PHOTO LIBRARY

Caption

Vioxx (rofecoxib) molecule, computer model. Vioxx was a COX-2 inhibitor painkilling drug marketed by Merck & Co. It was withdrawn in 2004 due to fears that its use may increase the risk of having a heart attack or stroke. In August 2005, a US court awarded a woman $253.4m (£141m) in compensation after her husband died while taking Vioxx. The finding could open up a path for thousands of similar lawsuits from people whose health suffered while on Vioxx. Around two million people are thought to have taken Vioxx worldwide since it was launched in 1999. Statistically, that could mean nearly 30,000 deaths relate to its use. In this molecule, carbon is grey, oxygen red, hydrogen blue, and sulphur yellow.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}